1. Home
  2. SNY vs MO Comparison

SNY vs MO Comparison

Compare SNY & MO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNY
  • MO
  • Stock Information
  • Founded
  • SNY 1994
  • MO 1822
  • Country
  • SNY France
  • MO United States
  • Employees
  • SNY N/A
  • MO N/A
  • Industry
  • SNY Biotechnology: Pharmaceutical Preparations
  • MO Medicinal Chemicals and Botanical Products
  • Sector
  • SNY Health Care
  • MO Health Care
  • Exchange
  • SNY Nasdaq
  • MO Nasdaq
  • Market Cap
  • SNY 116.1B
  • MO 112.0B
  • IPO Year
  • SNY N/A
  • MO N/A
  • Fundamental
  • Price
  • SNY $51.00
  • MO $63.45
  • Analyst Decision
  • SNY Buy
  • MO Buy
  • Analyst Count
  • SNY 4
  • MO 9
  • Target Price
  • SNY $61.50
  • MO $60.00
  • AVG Volume (30 Days)
  • SNY 3.1M
  • MO 7.4M
  • Earning Date
  • SNY 10-24-2025
  • MO 10-30-2025
  • Dividend Yield
  • SNY 3.11%
  • MO 6.56%
  • EPS Growth
  • SNY 105.93
  • MO N/A
  • EPS
  • SNY 8.67
  • MO 5.17
  • Revenue
  • SNY $53,890,648,839.00
  • MO $20,259,000,000.00
  • Revenue This Year
  • SNY $1.40
  • MO $1.87
  • Revenue Next Year
  • SNY $6.67
  • MO $0.22
  • P/E Ratio
  • SNY $11.67
  • MO $12.33
  • Revenue Growth
  • SNY N/A
  • MO N/A
  • 52 Week Low
  • SNY $44.62
  • MO $49.73
  • 52 Week High
  • SNY $60.12
  • MO $68.60
  • Technical
  • Relative Strength Index (RSI)
  • SNY 59.74
  • MO 40.42
  • Support Level
  • SNY $49.62
  • MO $62.95
  • Resistance Level
  • SNY $52.20
  • MO $64.97
  • Average True Range (ATR)
  • SNY 0.66
  • MO 0.93
  • MACD
  • SNY 0.19
  • MO -0.17
  • Stochastic Oscillator
  • SNY 72.42
  • MO 11.87

About SNY Sanofi ADS

Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for approximately 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.

About MO Altria Group Inc.

Altria comprises Philip Morris USA, US Smokeless Tobacco, John Middleton, Horizon Innovations, and Helix Innovations. Through its tobacco subsidiaries, Altria maintains the leading position in cigarettes and smokeless tobacco in the United States and the number-two spot in machine-made cigars. The company's Marlboro brand is the leading cigarette brand in the US with 42% annual share in 2024. Beyond its core business, it holds an 8% interest in the world's largest brewer, Anheuser-Busch InBev and a 41% stake in cannabis manufacturer Cronos. It also acquired vaping company Njoy Holdings in 2023 and operates a joint venture with Japan Tobacco in the heated tobacco category for the US.

Share on Social Networks: